NEW YORK ( TheStreet) -- CHANGE IN RATINGS
AmerisourceBergen (ABC) was downgraded at Leerink Swann to Market Perform. Industry is facing growth headwinds, Leerink Swann said.
Abercrombie & Fitch (ANF) was upgraded at Wedbush from Neutral to Outperform. $45 price target. Earnings visibility is improving and the current valuation is compelling, Wedbush said.
Bally Technologies (BYI) was downgraded at Deutsche Bank from Buy to Hold. $49 price target. Company is operating in a difficult environment, Deutsche said.Costar (CSGP) was downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. Valuation call, based on a $73 price target, Morgan Stanley said. Convergys (CVG) was downgraded at Oppenheimer from Outperform to Perform. Valuation call, as the stock has gained 23% year-to-date, Oppenheimer said. Genomic Health (GHDX) was initiated at Bank of America/Merrill Lynch with a Buy rating. $44 price target. Company has a strong track record for innovation and execution, BofA/Merrill said. GNC (GNC) was downgraded at Deutsche Bank from Buy to Hold. $42 price target. Valuation call, as the stock is up 30% since early January. Deutsche said. Georgia Gulf (GGS) was downgraded to Sell at TheStreet Ratings. Kinder Morgan (KMI) was upgraded at JP Morgan from Neutral to Overweight. $39 price target. Growth visibility is improving, JP Morgan said. Northwestern (NWE) was upgraded at Keybanc from Hold to Buy. $39 price target. Stock has underperformed its peers, but the company has attractive investment opportunities, Keybanc said. Oi SA (OIBR) was downgraded to Sell at TheStreet Ratings. Sina Corp. (SINA) was downgraded at Jefferies to Hold from Buy. $56 price target. Monetization takes time, Jefferies said. Sprint Nextel (S) was upgraded to Hold at TheStreet Ratings. Staples (SPLS) was downgraded to Sell from Neutral, Citigroup said. $10 price target. 2Q results sink on ongoing challenges, Citi said. Steel Dynamics (STLD) was upgraded to Buy at TheStreet Ratings.
STOCK COMMENTS / EPS CHANGESAgilent Technologies (A) numbers were lowered at Jefferies. Shares are now seen reaching $55. Estimates were also lowered on fierce cyclical headwinds, Jefferies said. Buy rating. Agilent numbers were lowered at Citigroup. Shares are now seen reaching $46. Estimates also lowered on third-quarter shortfall and more challenging outlook, Citi said. Buy rating. Abercrombie & Fitch numbers were raised at UBS. Shares are now seen reaching $36. Estimates also raised on anticipation of share repurchase, UBS said. Neutral rating. Salesforce.com (CRM) numbers raised at ThinkEquity. Shares are now seen reaching $165. Estimates were also increased, following channel checks, ThinkEquity said. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV